This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

SenoRx, Javelin: Early Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Friday's session.

SenoRx (SENO) surged by $1.69, or 33.4%, to $6.75 in the premarket session after the company was found not liable for patent infringement. Hologic (HOLX) had brought the lawsuit against SenoRx, alleging that it infringed claims of Hologic's 6,413,204 and 6,482,142 patents. The 50-day average daily volume for SenoRx is 39,000 shares, according to the Nasdaq.

Javelin Pharmaceuticals (JAV) jumped by 20 cents, or 16.3%, to $1.43 in the premarket session after Myriad Pharmaceuticals (MYRX) said it will acquire all outstanding shares of Javelin common stock in exchange for Myriad Pharmaceuticals stock, resulting in the Javelin stockholders owning approximately 41% of the combined company immediately after the closing. The three-month average daily volume for Javelin is 342,000, according to Yahoo! Finance.

Zale (ZLC) slumped by 21 cents, or 8.3%, to $2.32 in the premarket session after The Wall Street Journal reported that the company cancelled some orders with suppliers as it continues to struggle with mounting debt and declining sales. Zale refused to accept tens of million of dollars of inventory at the end of November and is stretching payments, according to diamond suppliers familiar with the matter, the paper said. The three-month average daily volume for Zale is 765,000.

E*Trade Financial (ETFC) rose by 6 cents, or 3.7%, to $1.67 in the premarket session after an analyst at Bank of America/Merrill Lynch has resumed coverage on the stock with a buy rating. The 50-day average daily volume for E*Trade is 55.2 million.

Alliance Imaging (AIQ - Get Report) tumbled by 61 cents, or 10.1%, to $5.45 in the premarket session after the company said it expects full-year revenue of $470 million to $500 million in 2010, compared to the Thomson Reuters average estimate of $508.4 million. The three-month average daily volume for Alliance Imaging is 260,000.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ZLC $21.02 -0.66%
MYRX $0.11 -7.23%
AIQ $22.44 1.20%
ETF $12.74 1.40%
AAPL $124.20 -0.18%


DOW 17,698.68 -77.44 -0.44%
S&P 500 2,060.93 -6.96 -0.34%
NASDAQ 4,873.8690 -27.0160 -0.55%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs